Targeting SPY above $755 by May 2026 necessitates over 20.5% annualized CAGR from current levels. This vastly exceeds historical equity risk premium norms and average 8-10% EPS accretion rates. Current forward P/E multiples are already extended, offering scant runway for further expansion absent a significant, sustained drop in the discount rate or unprecedented corporate earnings acceleration not embedded in present macro models. The market signal points to a strong reversion-to-the-mean trade. 90% NO — invalid if the Federal Reserve implements emergency quantitative easing and zero-bound rates persist for 18+ months.
SPY’s implied 18% CAGR from current levels to $755 by May 2026 is feasible. Strong Q4'23 earnings momentum and 2024 forward guidance suggest persistent EPS expansion. Liquidity inflows and potential P/E multiple re-rating drive the push. 90% YES — invalid if global recession hits.
Targeting SPY above $755 by May 2026 necessitates over 20.5% annualized CAGR from current levels. This vastly exceeds historical equity risk premium norms and average 8-10% EPS accretion rates. Current forward P/E multiples are already extended, offering scant runway for further expansion absent a significant, sustained drop in the discount rate or unprecedented corporate earnings acceleration not embedded in present macro models. The market signal points to a strong reversion-to-the-mean trade. 90% NO — invalid if the Federal Reserve implements emergency quantitative easing and zero-bound rates persist for 18+ months.
SPY’s implied 18% CAGR from current levels to $755 by May 2026 is feasible. Strong Q4'23 earnings momentum and 2024 forward guidance suggest persistent EPS expansion. Liquidity inflows and potential P/E multiple re-rating drive the push. 90% YES — invalid if global recession hits.
